Pubblicazioni del gruppo in riviste internazionali negli ultimi 5 anni

1.     Ziccardi S, Crescenzo F, Calabrese M. "What Is Hidden behind the Mask?"Facial Emotion Recognition at the Time of COVID-19 Pandemic in Cognitively Normal Multiple Sclerosis Patients. Diagnostics (Basel). 2021 Dec 27;12(1):47.

2.     Cerea S, Ghisi M, Pitteri M, Guandalini M, Strober LB, Scozzari S, Crescenzo F, Calabrese M. Coping Strategies and Their Impact on Quality of Life and Physical Disability of People with Multiple Sclerosis. J Clin Med. 2021 Nov 29;10(23):5607.

3.     Sormani MP, Schiavetti I, Carmisciano L, Cordioli C, Filippi M, Radaelli M, Immovilli P, Capobianco M, De Rossi N, Brichetto G, Cocco E, Scandellari C,Cavalla P, Pesci I, Zito A, Confalonieri P, Marfia GA, Perini P, Inglese M, Trojano M, Brescia Morra V, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; MuSC-19 Study Group. COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context. Neurol Neuroimmunol Neuroinflamm. 2021 Nov 9;9(1):e1105.

4.     Marastoni D, Magliozzi R, Bolzan A, Pisani AI, Rossi S, Crescenzo F,Montemezzi S, Pizzini FB, Calabrese M. CSF Levels of CXCL12 and Osteopontin asEarly Markers of Primary Progressive Multiple Sclerosis. Neurol Neuroimmunol Neuroinflamm. 2021 Sep 29;8(6):e1083.

5.     Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, Cavalla P, Torri Clerici V, Ragonese P, Nociti V, Radaelli M, Laroni A, Buttari F, Lorefice L, Ferraro D, Gajofatto A, Prosperini L, Fantozzi R, Boffa L, Lanzillo R, Moccia M, Clerico M,De Luca G, Tomassini V, Calabrese M, Borrelli A, Paolicelli D, Maniscalco GT, Gazzola P, Gallo A, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2021 Aug 18:jnnp-2021-327200. doi: 10.1136/jnnp-2021-327200.

6.     Bajrami A, Magliozzi R, Pisani AI, Pizzini FB, Crescenzo F, Marastoni D,Calabrese M. Volume changes of thalamus, hippocampus and cerebellum are associated with specific CSF profile in MS. Mult Scler. 2021 Aug

7.     Magliozzi R, Pezzini F, Pucci M, Rossi S, Facchiano F, Marastoni D Montagnana M, Lippi G, Reynolds R, Calabrese M. Changes in Cerebrospinal Fluid Balance of TNF and TNF Receptors in Naïve Multiple Sclerosis Patients: Early Involvement in Compartmentalised Intrathecal Inflammation. Cells. 2021 Jul 6;10(7):1712.

8.     Sormani MP, Schiavetti I, Landi D, Carmisciano L, De Rossi N, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Brescia Morra V, Trojano M, Tedeschi G, Comi G, Battaglia MA, Patti F, Fragoso YD, Sen S, Siva A, Furlan R, Salvetti M; MuSC-19 Study Group. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study. Mult Scler. 2021 Jul 30:

9.     Pitteri M, Magliozzi R, Nicholas R, Ziccardi S, Pisani AI, Pezzini F, Marastoni D, Calabrese M. Cerebrospinal fluid inflammatory profile of cognitive impairment in newly diagnosed multiple sclerosis patients. Mult Scler. 2021 Jul 30:

10.     Sormani MP, Salvetti M, Labauge P, Schiavetti I, Zephir H, Carmisciano L,Bensa C, De Rossi N, Pelletier J, Cordioli C, Vukusic S, Moiola L, Kerschen P, Radaelli M, Théaudin M, Immovilli P, Casez O, Capobianco M, Ciron J, Trojano M, Stankoff B, Créange A, Tedeschi G, Clavelou P, Comi G, Thouvenot E, Battaglia MA, Moreau T, Patti F, De Sèze J, Louapre C; Musc-19; Covisep study groups. DMTs and Covid-19 severity in MS: a pooled analysis from Italy and France. Ann Clin Transl Neurol. 2021 Aug;8(8):1738-1744.

11.     Pitteri M, Galazzo IB, Brusini L, Cruciani F, Dapor C, Marastoni D, Menegaz G, Calabrese M. Microstructural MRI Correlates of Cognitive Impairment in Multiple Sclerosis: The Role of Deep Gray Matter. Diagnostics (Basel). 2021 Jun 16;11(6):1103.

12.     Boscolo Galazzo I, Brusini L, Akinci M, Cruciani F, Pitteri M, Ziccardi S, Bajrami A, Castellaro M, Salih AMA, Pizzini FB, Jovicich J, Calabrese M, Menegaz G. Unraveling the MRI-Based Microstructural Signatures Behind Primary Progressive and Relapsing-Remitting Multiple Sclerosis Phenotypes. J Magn Reson Imaging. 2022 Jan;55(1):154-163. doi: 10.1002/jmri.27806. Epub 2021 Jun 30. PMID: 34189804.

13.     Cruciani F, Brusini L, Zucchelli M, Retuci Pinheiro G, Setti F, Boscolo Galazzo I, Deriche R, Rittner L, Calabrese M, Menegaz G. Interpretable deep learning as a means for decrypting disease signature in multiple sclerosis. J Neural Eng. 2021 Jul 19;18(4). doi: 10.1088/1741-2552/ac0f4b. PMID: 34181581.

14.     Messina S, Mariano R, Roca-Fernandez A, Cavey A, Jurynczyk M, Leite MI, Calabrese M, Jenkinson M, Palace J. Contrasting the brain imaging features of MOG-antibody disease, with AQP4-antibody NMOSD and multiple sclerosis. Mult Scler. 2022 Feb;28(2):217-227. doi: 10.1177/13524585211018987. Epub 2021 May 28.

15.     Granziera C, Wuerfel J, Barkhof F, Calabrese M, De Stefano N, Enzinger C, Evangelou N, Filippi M, Geurts JJG, Reich DS, Rocca MA, Ropele S, Rovira À, Sati P, Toosy AT, Vrenken H, Gandini Wheeler-Kingshott CAM, Kappos L; MAGNIMS Study Group. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain. 2021 Jun 22;144(5):1296-1311.

16.     Crescenzo F, Marastoni D, Pisani AI, Tamanti A, Dapor C, Colombi A, Brillo A, Magliozzi R, Pizzini FB, Castellaro M, Calabrese M. The Prognostic Value of White-Matter Selective Double Inversion Recovery MRI Sequence in Multiple Sclerosis: An Exploratory Study. Diagnostics (Basel). 2021 Apr 12;11(4):686.

17.     Ferraro D, Annovazzi P, Lanzillo R, Calabrese M, Fantozzi R, De Luca G, Cordioli C, Paolicelli D, Ragonese P, Gajofatto A, Lo Fermo S, Cavalla P, Tortorella C, Pesci I, Gallo A, Pinardi F, Di Filippo M, Maniscalco GT, Nociti V, Radaelli M, Tomassini V, Buscarinu MC, Moccia M, Camera V, Cocco E, Gasperini C, Solaro C. A multicenter survey on access to care in Multiple Sclerosis- related trigeminal neuralgia. J Neurol Sci. 2021 May 15;424:117430.

18.     Pisani AI, Scalfari A, Crescenzo F, Romualdi C, Calabrese M. A novel prognostic score to assess the risk of progression in relapsing-remitting multiple sclerosis patients. Eur J Neurol. 2021 Apr 9.

19.     Pitteri M, Dapor C, Ziccardi S, Guandalini M, Meggiato R, Calabrese M. A Videogame-Based Approach to Measuring Information Processing Speed in Multiple Sclerosis Patients. Games Health J. 2021 Apr;10(2):115-120

20.     Ziccardi S, Pitteri M, Genova HM, Calabrese M. Social Cognition in Multiple Sclerosis: A 3-Year Follow-Up MRI and Behavioral Study. Diagnostics (Basel). 2021 Mar 9;11(3):484.

21.     Calabrese M, Marastoni D, Crescenzo F, Scalfari A. Early multiple sclerosis: diagnostic challenges in clinically and radiologically isolated syndrome patients. Curr Opin Neurol. 2021 Jun 1;34(3):277-285

22.     Magliozzi R, Pitteri M, Ziccardi S, Pisani AI, Montibeller L, Marastoni D, Rossi S, Mazziotti V, Guandalini M, Dapor C, Schiavi G, Tamanti A, Nicholas R, Reynolds R, Calabrese M. CSF parvalbumin levels reflect interneuron loss linked with cortical pathology in multiple sclerosis. Ann Clin Transl Neurol. 2021 Mar;8(3):534-547

23.     Sormani MP, De Rossi N, Schiavetti I, Carmisciano L, Cordioli C, Moiola L, Radaelli M, Immovilli P, Capobianco M, Trojano M, Zaratin P, Tedeschi G, Comi G, Battaglia MA, Patti F, Salvetti M; Musc-19 Study Group. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021 Apr;89(4):780-789.

24.     Masuccio FG, Gamberini G, Calabrese M, Solaro C. Imaging and depression in multiple sclerosis: a historical perspective. Neurol Sci. 2021 Mar;42(3):835-845.

25.     Castellaro M, Tamanti A, Pisani AI, Pizzini FB, Crescenzo F, Calabrese M. The Use of the Central Vein Sign in the Diagnosis of Multiple Sclerosis: A Systematic Review and Meta-analysis. Diagnostics (Basel). 2020 Nov 29;10(12):1025.

26.     Pitteri M, Dapor C, Ziccardi S, Guandalini M, Meggiato R, Calabrese M. Visual-Attentional Load Unveils Slowed Processing Speed in Multiple Sclerosis Patients: A Pilot Study with a Tablet-Based Videogame. Brain Sci. 2020 Nov 18;10(11):871.

27.     Magliozzi R, Mazziotti V, Montibeller L, Pisani AI, Marastoni D, Tamanti A, Rossi S, Crescenzo F, Calabrese M. Cerebrospinal Fluid IgM Levels in Association With Inflammatory Pathways in Multiple Sclerosis Patients. Front Cell Neurosci. 2020 Oct 16;14:569827.

28.     Magliozzi R, Marastoni D, Calabrese M. The BAFF / APRIL system as therapeutic target in multiple sclerosis. Expert Opin Ther Targets. 2020 Sep 8.

29.     Crescenzo F, Marastoni D, Bovo C, Calabrese M. Frequency and severity of COVID-19 in multiple sclerosis: A short single-site report from northern Italy. Mult Scler Relat Disord. 2020 Jul 4;44:102372.

30.     Zanoni M, Orlandi E, Rossetti G, Turatti M, Calabrese M, Gomez Lira M, Gajofatto A. Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients. Acta Neurol Scand. 2020 May 20.

31.     Magliozzi R, Scalfari A, Pisani AI, Ziccardi S, Marastoni D, Pizzini FB, Bajrami A, Tamanti A, Guandalini M, Bonomi S, Rossi S, Mazziotti V, Castellaro M, Montemezzi S, Rasia S, Capra R, Pitteri M, Romualdi C, Reynolds R, CalabreseM. The CSF Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity. Ann Neurol. 2020 May 17.  

32.     Pitteri M, Vannucci M, Ziccardi S, Beccherle M, Semenza C, Calabrese M. False memories in relapsing remitting multiple sclerosis patients: A preliminary investigation with the DRM paradigm. Mult Scler Relat Disord. 2020 Jan;37:101418.  

33.     Pitteri M, Dapor C, Pisani AI, Castellaro M, DeLuca J, Chiaravalloti N, Guandalini M, Ziccardi S, Calabrese M. Executive functioning affects verbal learning process in multiple sclerosis patients: Behavioural and imaging results. J Neuropsychol. 2019 Nov 30.  

34.     Magliozzi R, Hametner S, Facchiano F, Marastoni D, Rossi S, Castellaro M, Poli A, Lattanzi F, Visconti A, Nicholas R, Reynolds R, Monaco S, Lassmann H, Calabrese M. Iron homeostasis, complement, and coagulation cascade as CSF signature of cortical lesions in early multiple sclerosis. Ann Clin Transl Neurol. 2019 Nov;6(11):2150-2163.

35.     Magliozzi R, Marastoni D, Rossi S, Castellaro M, Mazziotti V, Pitteri M, Gajofatto A, Monaco S, Benedetti MD, Calabrese M. Increase of CSF inflammatory profile in a case of highly active multiple sclerosis. BMC Neurol. 2019 Sep 26;19(1):231.

36.     Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, Pitiot A, Giorgio A, Schoonheim MM, Paul F, Pawlak MA, Schmidt R, Kappos L, Montalban X, Rovira À, Evangelou N, Wuerfel J; MAGNIMS Study Group. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis. JAMA Neurol. 2019 Dec 1;76(12):1446-1456.

37.     Marastoni D, Buriani A, Pisani AI, Crescenzo F, Zuco C, Fortinguerra S, Sorrenti V, Marenda B, Romualdi C, Magliozzi R, Monaco S, Calabrese M. Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study. Front Immunol. 2019 Jul 19;10:1666.

38.     Calabrese M, Gasperini C, Tortorella C, et al "Better explanations" in multiple sclerosis diagnostic workup: A 3-year longitudinal study. Neurology.2019 May 28;92(22):e2527-e2537.

39.     M, Ziccardi S, Dapor C, Guandalini M, Calabrese M. Lost in Classification: Lower Cognitive Functioning in Apparently Cognitive Normal Newly. Diagnosed RRMS Patients. Brain Sci. 2019 Nov 13;9(11):321.

40.     Pitteri M, Genova H, Lengenfelder J, DeLuca J, Ziccardi S, Rossi V, Calabrese M. Social cognition deficits and the role of amygdala in relapsing remitting multiple sclerosis patients without cognitive impairment. Mult Scler Relat Disord. 2019 Jan 23;29:118-123.

41.     Magliozzi R, Reynolds R, Calabrese M. MRI of cortical lesions and its use in studying their role in MS pathogenesis and disease course. Brain Pathol. 2018 Sep;28(5):735-742.

42.     Bajrami A, Pitteri M, Castellaro M, Pizzini F, Romualdi C, Montemezzi S,Monaco S, Calabrese M. The effect of fingolimod on focal and diffuse grey matter  damage in active MS patients. J Neurol. 2018 Jun 25.

43.     Amiri H, de Sitter A, Bendfeldt K, Battaglini M, Gandini Wheeler-Kingshott CAM, Calabrese M, Geurts JJG, Rocca MA, Sastre-Garriga J, Enzinger C, de Stefano N, Filippi M, Rovira Á, Barkhof F, Vrenken H; MAGNIMS Study Group. Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI. Neuroimage Clin. 2018 Apr 26;19:466-475.  

44.     Calabrese M. Multiple sclerosis and epilepsy: much more than a coincidence.Eur J Neurol. 2018 Sep;25(9):1103-1104.

45.     Scalfari A, Romualdi C, Nicholas RS, Mattoscio M, Magliozzi R, Morra A, Monaco S, Muraro PA, Calabrese M. The cortical damage, early relapses, and onset of the  progressive phase in multiple sclerosis. Neurology. 2018 May 16

46.     Magliozzi R, Howell OW, Nicholas R, Cruciani C, Castellaro M, Romualdi C, Rossi S, Pitteri M, Benedetti MD, Gajofatto A, Pizzini FB, Montemezzi S, Rasia S, Capra R, Bertoldo A, Facchiano F, Monaco S, Reynolds R, Calabrese M. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann Neurol. 2018  Mar

47.     Calabrese M, Pitteri M, Farina G, Bajrami A, Castellaro M, Magliozzi R, Monaco S. Dimethyl fumarate: a possible exit strategy from natalizumab treatment in patients with multiple sclerosis at risk for severe adverse events. J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1073-1078.